Introduction Gut microbiota-dependent trimethylamine-N-oxide (TMAO) correlates with
arterial thrombotic events including myocardial infarction and stroke, and mortality. However …

Abstract Background: Trimethylamine-N-oxide (TMAO) is formed in the liver from
trimethylamine (TMA), a product exclusively generated by the gut microbiota from dietary …

Abstract Trimethylamine-N-Oxide (TMAO) is a microbiome-related metabolite that is cleared
by the kidney and linked to renal function. We explored the relationship between TMAO and …

Trimethylamine N-oxide (TMAO), a metabolite derived from intestine microbial flora,
enhances vascular inflammation in a variety of cardiovascular diseases, and the bacterial …

Abstract Background Trimethylamine-N-oxide (TMAO) is a metabolite of phosphatidylcholine
generated by gut microbiota and liver enzymes, and has recently been recognized as …

During the past decade, meta-omics approaches have revolutionized microbiology, allowing
for a cultivation-free assessment of the composition and functional properties of entire …

The gut microbial metabolite trimethylamine N-oxide (TMAO) promotes atherosclerosis and
cardiovascular diseases. TMAO levels are associated with the coronary atherosclerotic …

The gut microbiota and its metabolites have become a hotspot of recent research.
Trimethylamine N-oxide (TMAO) metabolized by the gut microbiota is closely related to …

Background Gut microbiota has been suggested to play a role in almost all major diseases
including cardio‐and cerebrovascular diseases. A possible mechanism is the transformation …

Plasma trimethylamine N-oxide (TMAO) is associated with coronary atherosclerotic plaque
and cardiovascular disease risk, but associations between gut microbes in acute coronary …